CollPlant Biotechnologies (CLGN) Net Margin (QoQ) (2018 - 2026)

CollPlant Biotechnologies (CLGN) Net Margin (QoQ) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 CollPlant Biotechnologies 4.63 Mn 4.63 Mn -243,000.00

Historic Data

Download Data
DateValue
Mar 30, 2026 4.90 Mn
Dec 31, 2025 -4.88 Mn
Sep 30, 2025 -632,996.00
Jun 30, 2025 185,561.00
Mar 30, 2025 1.62 Mn
Dec 31, 2024 9.72 Mn
Sep 30, 2024 -11.53 Mn
Jun 30, 2024 -264,787.00
Mar 31, 2024 1.26 Mn
Dec 31, 2023 -813,879.00
Sep 30, 2023 -5,576.00
Jun 30, 2023 -75,696.00
Mar 31, 2023 4.76 Mn
Dec 31, 2022 -4.27 Mn
Sep 30, 2022 224,183.00
Dec 31, 2021 -12.48 Mn
Sep 30, 2021 5.18 Mn
Jun 30, 2021 -50,131.00
Mar 31, 2021 -7,134.00
Dec 31, 2020 -1.68 Mn